Cardiotoxicity of Immune Therapy.

Cardiotoxicity Global Health Heart Diseases / epidemiology Humans Immunity, Cellular Immunotherapy / adverse effects Incidence Neoplasms / therapy
CAR T-cell therapy Cardiotoxicity Chimeric antigen receptor Cytokine release syndrome Immune checkpoint inhibitor Immunotherapy Myocarditis

Journal

Cardiology clinics
ISSN: 1558-2264
Titre abrégé: Cardiol Clin
Pays: Netherlands
ID NLM: 8300331

Informations de publication

Date de publication:
Nov 2019
Historique:
entrez: 8 10 2019
pubmed: 8 10 2019
medline: 18 2 2020
Statut: ppublish

Résumé

The advent of immunotherapy, particularly immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy, has ushered in a promising new era of treatment of patients with a variety of malignancies who historically had a poor prognosis. However, these therapies are associated with potentially life-threatening cardiovascular adverse effects. As immunotherapy evolves to include a wider variety of malignancies, risk stratification, prompt recognition, and treatment of cardiotoxicity will become increasingly important and hence cardiologists will need to play a fundamental role in the comprehensive care of these patients. This article reviews cardiotoxicity associated with contemporary immunotherapy and discusses potential management strategies.

Identifiants

DOI: 10.1016/j.ccl.2019.07.008 PMID: 31587780
pubmed: 31587780
pii: S0733-8651(19)30057-8
doi: 10.1016/j.ccl.2019.07.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-397

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Sarju Ganatra (S)

Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital and Medical Center, 41 Mall road, Burlington, MA 01805, USA; Cardio-Oncology and Adult Cancer Survivorship Program, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address: sarju.ganatra@lahey.org.

Rohan Parikh (R)

Department of Medicine, Western Reserve Health Education, 1350 East Market St, Warren, OH 44482, USA.

Tomas G Neilan (TG)

Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; Cardiac MR/PET Program, Department of Radiology, Division of Cardiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiques › Rayonnement › Cardiotoxicité › Cardiotoxicity of Immune Therapy.
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mondiale › Cardiotoxicity of Immune Therapy.
questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › Cardiotoxicity of Immune Therapy.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cardiotoxicity of Immune Therapy.
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Immunité cellulaire › Cardiotoxicity of Immune Therapy.
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › Cardiotoxicity of Immune Therapy.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Incidence › Cardiotoxicity of Immune Therapy.
questionsmedicales.fr › Tumeurs › Cardiotoxicity of Immune Therapy.